Narcotine, compd. with 7,8-didehydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol and 3-hydroxy-4-oxo-4H-pyran-2,6-dicarboxylic acid (1:1:1) (6055-90-9)

Other Product

• 1-Bromo-7,8-didehydro-4,5α-epoxy-3-hydroxy-17-methylmorphinan-6-one
• Morphinan-6-ol, 8,14-didehydro-4, 5-epoxy-3-methoxy-17-methyl-, hydrobromide, (5.alpha.,6.alpha.)-
• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-17-methyl-3-(2-(4-morpholinyl)ethoxy)-, (5alpha,6alpha)-, mixt. with (R*,S*)-(+-)-alpha-(1-aminoethyl)benzenemethanol and N-(4-hydroxyphenyl)acetamide
• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with endo-(+-)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl alpha-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt), sodium ((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonate and N,N,alpha-trimethyl-10H-phenothiazine-10-ethanamine
• Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro- 4-hydroxy- 6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha-(R*),3-alpha,7-beta, 8-beta-(2S*,4S*),8a-beta))-
• 5-oxo-L-proline, compound with (5α,6α)-7,8-didehydro-4,5-epoxy-3-ethoxy-17-methylmorphinan-6-ol (1:1)
• 5-oxo-L-proline, compound with (5α,6α)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol (1:1)
• 7,8-didehydro-6α-hydroxy-4,5α-epoxy-3-ethoxy-17-methylmorphinan (1S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulphonate
• 24-Nor-6,7-secochola-14,20,22-trien-6-al, 7-((2-(4-chlorophenyl)ethyl)imino)-21,23-epoxy-4,4,8-trimethyl-3-oxo-, (5-beta,13-alpha,17-alpha)-
• Tetracyclo[5.2.1.02,6.03,5]dec-8-ene,(1α,2α,3β,5β,6α,7α)- (9CI)
• 3-(alpha-L-arabinofuranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl 6-deoxy-alpha-L-mannopyranoside
• 5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-oxo-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->3)-6-deoxy-alpha-L-mannopyranosyl-(1->6)-beta-D-galactopyranoside
• 1,4-Benzenedicarboxylic acid, compd. with (5alpha)-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
• 6,7-Didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6-ol
• 4-Thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-7-oxo-3-(4-piperidinylthio)-, (5R-(5-alpha,6-alpha(R*)))-
• Ethanaminium, 2-(1-bicyclo(2.2.1)hept-5-en-2-yl-1-phenylethoxy)-N,N-diethyl-N-methyl-, bromide, mixt. with 7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol (5alpha,6alpha)-, phosphate (1:1) (salt), and sodium ((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonate
• 7,8-Didehydro-4,5α-epoxy-17-methylmorphinan-3,6α-diol 6-formate
• Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11alpha,13E,15S)-, compd. with (S)-7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one monomethyl ether (1:1)
• 3-{[4-O-acetyl-6-deoxy-3-O-(2,6-di-O-acetyl-beta-D-glucopyranosyl)-alpha-L-mannopyranosyl]oxy}-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside
• Morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5-alpha,6-alpha)-, phosphate (1:1) (salt), mixt. with (R-(R*,S*))-alpha-(1-(methylamino)ethyl)benzenemethanol hydrochloride